TABLE 3.
Sensitivity Analysis a
| Lead Author (Year) | Payment Perspective | Probability That Surgery Is Cost-effective | Sensitive Parameters for ICER |
|---|---|---|---|
| Clement (2014) 4 | Health care system | NR | Preoperative SF12-6D score |
| Griffin (2018) 14 | Health care system | 0.002 | None |
| Societal | Never | None | |
| Lodhia (2016) 20 | Societal | 0.945 | Utility of an asymptomatic hip after arthroscopy |
| Mather (2018) 22 | Societal | 0.99 | None |
| Scott (2020) 36 | Health care system | NR | NR |
| Shearer (2012) 37 | Health care system | 0.85 without OA 0.23 with OA |
Arthroscopy duration of benefit, improvement in utility postoperatively |
a NR, not reported; ICER, incremental cost-effectiveness ratio; OA, osteoarthritis; SF12-6D, 12-Item Short Form Health Survey 6 Dimensions.